News und Analysen
Neue renommierte wissenschaftliche Publikation von Carbios betont die Ausweitung der Forschungstätigkeit auf weitere Kunststoffe
Carbios (Euronext Growth Paris: ALCRB), ein Pionier in der Entwicklung und Industrialisierung enzymatischer Lösungen für das Recycling von Kunststoff- und Textilpolymeren, hat die Veröffentlichung
Poxel to Report its 2022 Full Year Results by the End of March 2023
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic
A New Prestigious Scientific Publication for Carbios Marks the Expansion of Its Research to Other Plastics
Regulatory News:
Carbios (Euronext Growth Paris: ALCRB) (Paris:ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastics and
Transgene: 2022 Full-year Results and Business Update
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today publishes its financial
EQS-News: Abivax adjusts its 2023 Financial Communication Calendar
GEVELOT S.A.: Weekly report of share buyback March 15, 2023
Prodware: Current Operating Income sees strong upturn: 29.3 M€ (+103%) Operating Margin: 15.6%
Poxel Announces Upcoming Participation at Evercore ISI’s NASH Renaissance Event
Regulatory News:
POXEL SA (Paris:POXEL) (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic
Transgene to Present Multiple Posters Highlighting the Potential of its Exciting Immunotherapy Pipeline at AACR 2023
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, will be presenting eight posters
Prodware: Prodware reinforces its presence in Europe with the acquisition of Westpole Belux
EQS-News: Abivax does not hold any cash or otherwise have any deposits at SVB or at any other U.S. financial institution
Transgene Appoints John C. Bell and Pedro Romero as Key Scientific Advisors
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces the appointment of Dr.
ESI Group: Simulierung ermöglicht integrativere und sicherere Industrie für Frauen und alle Menschen
Die ESI Group (Paris:ESI) (ISIN Code: FR0004110310, Symbol: ESI) ist ein weltweit tätiges Partnerunternehmen in Sachen Simulierung und Software für virtuelle Prototypenerstellung für diverse
ESI Group: A More Inclusive and Safer Industry for Women and Everyone Thanks to Simulation
Regulatory News:
ESI Group (Paris:ESI) (ISIN Code: FR0004110310, Symbol: ESI) is a global partner in simulation and virtual prototyping software for various industries. The company is committed
Verimatrix erhält Top-Auszeichnungen für Sicherheit mit künstlicher Intelligenz und Markenwachstum bei den Cybersecurity Excellence Awards 2023
Verimatrix, (Paris:VMX) (Euronext Paris: VMX), der führende Anbieter von menschengerechten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass das Unternehmen bei den
Verimatrix Wins Top Prizes for Artificial Intelligence Security and Brand Growth in 2023 Cybersecurity Excellence Awards
Regulatory News:
Verimatrix, (Paris:VMX) (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the company received two gold
Poxel Announces Publication of Positive Phase 2 Results from Phase 2 NASH Trial (DESTINY-1) for PXL065 in Journal of Hepatology
Regulatory News:
POXEL SA (Euronext : POXEL – FR0012432516), clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology
Poxel Announces Publication in Kidney International of PXL770 Preclinical Results in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Regulatory News:
POXEL SA (Paris:POXEL) (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic
Prodware: Business Accelerating in 2022: €188.3 M (+13.7%)
Freelance.com: Freelance.com generates over €800m in revenue in 2022
EQS-News: Abivax publishes a prospectus in the context of its capital increase
Axway Software : Excellent 2022 Full-Year Results Supported by Record High Q4
Regulatory News:
Axway Software's (Paris:AXW) Board of Directors today conducted an in-depth review of the consolidated and annual financial statements2 for the year ended December 31, 2022. As a
Prodware: Phast Invest, holding company of the Prodware group has raised €20 M with Tikehau Capital and Prodware’s Historical Managers
EQS-News: Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer